SCHEMBL21173000

SCHEMBL21173000

CC[C@H]1C(C)Cc2cc(C(N)=O)ccc2N1C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41
BRD4 O60885 7/20 0.41
CCL2 P13500 2/20 0.41
BRD2 P25440 2/20 0.41
BRD3 Q15059 2/20 0.41
EP300 Q09472 1/20 0.41
BRDT Q58F21 1/20 0.41
CREBBP Q92793 1/20 0.41
HSD17B3 P37058 1/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
NOTUM Q6P988 1/20 0.39
CTPS1 P17812 1/20 0.39
KMT2A Q03164 1/20 0.38
TNF P01375 1/20 0.37
RAB9A P51151 1/20 0.37
NOD2 Q9HC29 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30083874 0.89 TDP1 (0.41) KDM4EALDH1A1HSD17B10BRD4BRD2
SCHEMBL21172800 0.89 TDP1 (0.41) KDM4EALDH1A1HSD17B10BRD4BRD2
SCHEMBL21172676 0.85 MAPT (0.38) ALDH1A1BRD4MAPTHPGDNOTUM
SCHEMBL21172602 0.85 MAPT (0.38) ALDH1A1BRD4MAPTHPGDNOTUM
SCHEMBL21172656 0.85 KDM4E (0.46) KDM4EALDH1A1HSD17B10HSD17B3MAPT
SCHEMBL24347614 0.84 SRD5A1 (0.43) KDM4EALDH1A1MAPTHPGDTP53
SCHEMBL21172626 0.84 SRD5A1 (0.43) KDM4EALDH1A1MAPTHPGDTP53
SCHEMBL21173200 0.84 KDM4E (0.45) KDM4EALDH1A1HSD17B10BRD4CCL2
SCHEMBL24347574 0.83 NOTUM (0.43) BRD4NOTUMKMT2ATNFNOD2
SCHEMBL24347577 0.82 KMT2A (0.42) ALDH1A1NOTUMKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511323-A1 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS GlaxoSmithKline Intellectual Property (No.2) Limited (GB) 2019-07-17 EP disclosed